Machatha Stephen

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$174,580.14

Insider Activity of Machatha Stephen

According to the SEC Form 4 filings, Machatha Stephen, being in a position of

  1. Chief Development Officer at Aldeyra Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 45809 shares for $174,580,
    over all time since 2024-03-11, has bought 0 shares, and sold 45809 shares for $174,580.

The largest sale of all time was on 2024-08-12 and amounted to 16041 share of Aldeyra Therapeutics, Inc. for $75,975.

Biography of Machatha Stephen

No biography is available at this moment.

2024-08-12SaleAldeyra Therapeutics, Inc.
ALDX
Chief Development Officer
16,041
0.0272%
$4.74$75,975+12.63%
2024-03-12SaleAldeyra Therapeutics, Inc.
ALDX
Chief Development Officer
11,537
0.0206%
$3.16$36,503+41.2%
2024-03-11SaleAldeyra Therapeutics, Inc.
ALDX
Chief Development Officer
18,231
0.0324%
$3.41$62,102+30.77%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.